Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BE
8. FIX
9. NDAQ
10. TSCO

Go back to Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

AnaptysBio (ANAB) PT Lowered to $52 at H.C. Wainwright

November 6, 2024 6:12 AM EST

H.C. Wainwright analyst Emily Bodnar lowered the price target on AnaptysBio (NASDAQ: ANAB) to $52.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "3Q24 financial recap; lowering PT to $52 from $55. AnaptysBio had 3Q24 total operating expenses of $52.8M, which were slightly... More

AnaptysBio (ANAB) PT Lowered to $45 at Leerink Partners

November 6, 2024 5:58 AM EST

Leerink Partners analyst David Risinger lowered the price target on AnaptysBio (NASDAQ: ANAB) to $45.00 (from $47.00) while maintaining a Outperform rating.

The analyst comments " Bottom Line: ANAB reported 3Q results and stated that there have been no blinded safety issues to date with either its BTLA... More